nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—ovarian cancer	0.511	1	CbGaD
Fluticasone furoate—ABCB1—Topotecan—ovarian cancer	0.0843	0.221	CbGbCtD
Fluticasone furoate—ABCB1—Vinorelbine—ovarian cancer	0.0594	0.156	CbGbCtD
Fluticasone furoate—CYP3A4—Topotecan—ovarian cancer	0.0505	0.133	CbGbCtD
Fluticasone furoate—ABCB1—Paclitaxel—ovarian cancer	0.0418	0.11	CbGbCtD
Fluticasone furoate—CYP3A4—Vinorelbine—ovarian cancer	0.0356	0.0935	CbGbCtD
Fluticasone furoate—ABCB1—Docetaxel—ovarian cancer	0.0302	0.0793	CbGbCtD
Fluticasone furoate—CYP3A4—Paclitaxel—ovarian cancer	0.025	0.0657	CbGbCtD
Fluticasone furoate—ABCB1—Doxorubicin—ovarian cancer	0.0225	0.0591	CbGbCtD
Fluticasone furoate—CYP3A4—Docetaxel—ovarian cancer	0.0181	0.0475	CbGbCtD
Fluticasone furoate—CYP3A4—Doxorubicin—ovarian cancer	0.0135	0.0354	CbGbCtD
Fluticasone furoate—Impaired healing—Melphalan—ovarian cancer	0.00359	0.0353	CcSEcCtD
Fluticasone furoate—Nasal dryness—Paclitaxel—ovarian cancer	0.00231	0.0227	CcSEcCtD
Fluticasone furoate—Dry throat—Paclitaxel—ovarian cancer	0.00222	0.0219	CcSEcCtD
Fluticasone furoate—Sinus congestion—Paclitaxel—ovarian cancer	0.00183	0.0181	CcSEcCtD
Fluticasone furoate—Blood glucose increased—Paclitaxel—ovarian cancer	0.00178	0.0176	CcSEcCtD
Fluticasone furoate—Ulcer—Melphalan—ovarian cancer	0.00164	0.0162	CcSEcCtD
Fluticasone furoate—Pharyngolaryngeal pain—Paclitaxel—ovarian cancer	0.00135	0.0133	CcSEcCtD
Fluticasone furoate—Laryngeal pain—Paclitaxel—ovarian cancer	0.00134	0.0132	CcSEcCtD
Fluticasone furoate—Infection—Carboplatin—ovarian cancer	0.00123	0.0121	CcSEcCtD
Fluticasone furoate—Dizziness—Altretamine—ovarian cancer	0.00118	0.0116	CcSEcCtD
Fluticasone furoate—Pharyngolaryngeal pain—Docetaxel—ovarian cancer	0.00115	0.0113	CcSEcCtD
Fluticasone furoate—Laryngeal pain—Docetaxel—ovarian cancer	0.00113	0.0112	CcSEcCtD
Fluticasone furoate—Dysphonia—Paclitaxel—ovarian cancer	0.00111	0.0109	CcSEcCtD
Fluticasone furoate—Nausea—Altretamine—ovarian cancer	0.00106	0.0105	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Epirubicin—ovarian cancer	0.00103	0.0102	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Epirubicin—ovarian cancer	0.000992	0.00977	CcSEcCtD
Fluticasone furoate—Herpes simplex—Paclitaxel—ovarian cancer	0.00099	0.00975	CcSEcCtD
Fluticasone furoate—Body temperature increased—Carboplatin—ovarian cancer	0.000976	0.00961	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Doxorubicin—ovarian cancer	0.000956	0.00941	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Epirubicin—ovarian cancer	0.000954	0.00939	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Paclitaxel—ovarian cancer	0.00094	0.00926	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Doxorubicin—ovarian cancer	0.000918	0.00904	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Paclitaxel—ovarian cancer	0.000912	0.00898	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Doxorubicin—ovarian cancer	0.000883	0.00869	CcSEcCtD
Fluticasone furoate—Candida infection—Paclitaxel—ovarian cancer	0.000871	0.00857	CcSEcCtD
Fluticasone furoate—Epistaxis—Topotecan—ovarian cancer	0.000837	0.00824	CcSEcCtD
Fluticasone furoate—Pharyngitis—Topotecan—ovarian cancer	0.00079	0.00778	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Docetaxel—ovarian cancer	0.000773	0.00761	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Melphalan—ovarian cancer	0.000766	0.00754	CcSEcCtD
Fluticasone furoate—Fluticasone Propionate—PGR—ovarian cancer	0.000742	0.3	CrCbGaD
Fluticasone furoate—Candida infection—Docetaxel—ovarian cancer	0.000738	0.00727	CcSEcCtD
Fluticasone furoate—Tremor—Chlorambucil—ovarian cancer	0.000729	0.00718	CcSEcCtD
Fluticasone furoate—Immune system disorder—Topotecan—ovarian cancer	0.000719	0.00708	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Topotecan—ovarian cancer	0.000718	0.00706	CcSEcCtD
Fluticasone furoate—Agitation—Chlorambucil—ovarian cancer	0.000715	0.00704	CcSEcCtD
Fluticasone furoate—Angioedema—Chlorambucil—ovarian cancer	0.000711	0.007	CcSEcCtD
Fluticasone furoate—Immune system disorder—Melphalan—ovarian cancer	0.000704	0.00693	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Melphalan—ovarian cancer	0.000703	0.00692	CcSEcCtD
Fluticasone furoate—Visual disturbance—Paclitaxel—ovarian cancer	0.000699	0.00688	CcSEcCtD
Fluticasone furoate—Betamethasone—PGR—ovarian cancer	0.00068	0.275	CrCbGaD
Fluticasone furoate—Back pain—Topotecan—ovarian cancer	0.00067	0.0066	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Vinorelbine—ovarian cancer	0.000669	0.00659	CcSEcCtD
Fluticasone furoate—Dysphonia—Epirubicin—ovarian cancer	0.000634	0.00624	CcSEcCtD
Fluticasone furoate—Angioedema—Topotecan—ovarian cancer	0.000633	0.00623	CcSEcCtD
Fluticasone furoate—Infection—Chlorambucil—ovarian cancer	0.000631	0.00621	CcSEcCtD
Fluticasone furoate—Immune system disorder—Vinorelbine—ovarian cancer	0.000615	0.00606	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Vinorelbine—ovarian cancer	0.000614	0.00604	CcSEcCtD
Fluticasone furoate—Cough—Topotecan—ovarian cancer	0.000605	0.00595	CcSEcCtD
Fluticasone furoate—Visual disturbance—Docetaxel—ovarian cancer	0.000592	0.00583	CcSEcCtD
Fluticasone furoate—Cough—Melphalan—ovarian cancer	0.000592	0.00583	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Paclitaxel—ovarian cancer	0.000592	0.00583	CcSEcCtD
Fluticasone furoate—Dysphonia—Doxorubicin—ovarian cancer	0.000587	0.00577	CcSEcCtD
Fluticasone furoate—Back pain—Vinorelbine—ovarian cancer	0.000573	0.00565	CcSEcCtD
Fluticasone furoate—Herpes simplex—Epirubicin—ovarian cancer	0.000566	0.00557	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Topotecan—ovarian cancer	0.000566	0.00557	CcSEcCtD
Fluticasone furoate—Infection—Topotecan—ovarian cancer	0.000562	0.00553	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Topotecan—ovarian cancer	0.000555	0.00546	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Melphalan—ovarian cancer	0.000554	0.00545	CcSEcCtD
Fluticasone furoate—Migraine—Docetaxel—ovarian cancer	0.000552	0.00544	CcSEcCtD
Fluticasone furoate—Ulcer—Epirubicin—ovarian cancer	0.000551	0.00543	CcSEcCtD
Fluticasone furoate—Bronchitis—Paclitaxel—ovarian cancer	0.00055	0.00542	CcSEcCtD
Fluticasone furoate—Infection—Melphalan—ovarian cancer	0.00055	0.00542	CcSEcCtD
Fluticasone furoate—Angioedema—Vinorelbine—ovarian cancer	0.000542	0.00533	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Epirubicin—ovarian cancer	0.000538	0.00529	CcSEcCtD
Fluticasone furoate—Palpitations—Vinorelbine—ovarian cancer	0.000524	0.00516	CcSEcCtD
Fluticasone furoate—Herpes simplex—Doxorubicin—ovarian cancer	0.000524	0.00516	CcSEcCtD
Fluticasone furoate—Cough—Vinorelbine—ovarian cancer	0.000517	0.00509	CcSEcCtD
Fluticasone furoate—Ulcer—Doxorubicin—ovarian cancer	0.00051	0.00502	CcSEcCtD
Fluticasone furoate—Urticaria—Chlorambucil—ovarian cancer	0.000505	0.00497	CcSEcCtD
Fluticasone furoate—Dyspnoea—Topotecan—ovarian cancer	0.000504	0.00496	CcSEcCtD
Fluticasone furoate—Body temperature increased—Chlorambucil—ovarian cancer	0.000502	0.00495	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Docetaxel—ovarian cancer	0.000502	0.00494	CcSEcCtD
Fluticasone furoate—Candida infection—Epirubicin—ovarian cancer	0.000498	0.0049	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Doxorubicin—ovarian cancer	0.000497	0.0049	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Paclitaxel—ovarian cancer	0.000496	0.00488	CcSEcCtD
Fluticasone furoate—Dyspnoea—Melphalan—ovarian cancer	0.000494	0.00486	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000484	0.00476	CcSEcCtD
Fluticasone furoate—Epistaxis—Paclitaxel—ovarian cancer	0.000481	0.00474	CcSEcCtD
Fluticasone furoate—Infection—Vinorelbine—ovarian cancer	0.000481	0.00473	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Vinorelbine—ovarian cancer	0.000475	0.00467	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Chlorambucil—ovarian cancer	0.000468	0.00461	CcSEcCtD
Fluticasone furoate—Candida infection—Doxorubicin—ovarian cancer	0.000461	0.00454	CcSEcCtD
Fluticasone furoate—Pharyngitis—Paclitaxel—ovarian cancer	0.000455	0.00448	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00045	0.00443	CcSEcCtD
Fluticasone furoate—Urticaria—Topotecan—ovarian cancer	0.000449	0.00442	CcSEcCtD
Fluticasone furoate—Body temperature increased—Topotecan—ovarian cancer	0.000447	0.0044	CcSEcCtD
Fluticasone furoate—Visual impairment—Paclitaxel—ovarian cancer	0.000441	0.00435	CcSEcCtD
Fluticasone furoate—Urticaria—Melphalan—ovarian cancer	0.00044	0.00433	CcSEcCtD
Fluticasone furoate—Diarrhoea—Chlorambucil—ovarian cancer	0.000435	0.00428	CcSEcCtD
Fluticasone furoate—Dyspnoea—Vinorelbine—ovarian cancer	0.000431	0.00425	CcSEcCtD
Fluticasone furoate—Eye disorder—Paclitaxel—ovarian cancer	0.000428	0.00421	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Docetaxel—ovarian cancer	0.00042	0.00414	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Topotecan—ovarian cancer	0.000417	0.0041	CcSEcCtD
Fluticasone furoate—Immune system disorder—Paclitaxel—ovarian cancer	0.000414	0.00407	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000413	0.00406	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Melphalan—ovarian cancer	0.000408	0.00402	CcSEcCtD
Fluticasone furoate—Epistaxis—Docetaxel—ovarian cancer	0.000408	0.00402	CcSEcCtD
Fluticasone furoate—Dexamethasone—PGR—ovarian cancer	0.000395	0.16	CrCbGaD
Fluticasone furoate—Diarrhoea—Topotecan—ovarian cancer	0.000387	0.00381	CcSEcCtD
Fluticasone furoate—Back pain—Paclitaxel—ovarian cancer	0.000386	0.0038	CcSEcCtD
Fluticasone furoate—Pharyngitis—Docetaxel—ovarian cancer	0.000385	0.00379	CcSEcCtD
Fluticasone furoate—Urticaria—Vinorelbine—ovarian cancer	0.000384	0.00378	CcSEcCtD
Fluticasone furoate—Body temperature increased—Vinorelbine—ovarian cancer	0.000383	0.00377	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Docetaxel—ovarian cancer	0.000382	0.00376	CcSEcCtD
Fluticasone furoate—Diarrhoea—Melphalan—ovarian cancer	0.000379	0.00373	CcSEcCtD
Fluticasone furoate—Nausea—Chlorambucil—ovarian cancer	0.000377	0.00372	CcSEcCtD
Fluticasone furoate—Visual impairment—Docetaxel—ovarian cancer	0.000374	0.00368	CcSEcCtD
Fluticasone furoate—Dizziness—Topotecan—ovarian cancer	0.000374	0.00368	CcSEcCtD
Fluticasone furoate—Tremor—Paclitaxel—ovarian cancer	0.000374	0.00368	CcSEcCtD
Fluticasone furoate—Migraine—Epirubicin—ovarian cancer	0.000373	0.00367	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP1B1—ovarian cancer	0.00037	0.149	CrCbGaD
Fluticasone furoate—Agitation—Paclitaxel—ovarian cancer	0.000366	0.00361	CcSEcCtD
Fluticasone furoate—Angioedema—Paclitaxel—ovarian cancer	0.000364	0.00359	CcSEcCtD
Fluticasone furoate—Eye disorder—Docetaxel—ovarian cancer	0.000363	0.00357	CcSEcCtD
Fluticasone furoate—Rash—Topotecan—ovarian cancer	0.000357	0.00351	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vinorelbine—ovarian cancer	0.000356	0.00351	CcSEcCtD
Fluticasone furoate—Dermatitis—Topotecan—ovarian cancer	0.000356	0.00351	CcSEcCtD
Fluticasone furoate—Headache—Topotecan—ovarian cancer	0.000354	0.00349	CcSEcCtD
Fluticasone furoate—Palpitations—Paclitaxel—ovarian cancer	0.000352	0.00347	CcSEcCtD
Fluticasone furoate—Immune system disorder—Docetaxel—ovarian cancer	0.000351	0.00345	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Docetaxel—ovarian cancer	0.00035	0.00345	CcSEcCtD
Fluticasone furoate—Rash—Melphalan—ovarian cancer	0.000349	0.00344	CcSEcCtD
Fluticasone furoate—Dermatitis—Melphalan—ovarian cancer	0.000349	0.00343	CcSEcCtD
Fluticasone furoate—Cough—Paclitaxel—ovarian cancer	0.000348	0.00343	CcSEcCtD
Fluticasone furoate—Migraine—Doxorubicin—ovarian cancer	0.000345	0.00339	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Epirubicin—ovarian cancer	0.000339	0.00333	CcSEcCtD
Fluticasone furoate—Nausea—Topotecan—ovarian cancer	0.000336	0.00331	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vinorelbine—ovarian cancer	0.000331	0.00326	CcSEcCtD
Fluticasone furoate—Nausea—Melphalan—ovarian cancer	0.000329	0.00324	CcSEcCtD
Fluticasone furoate—Back pain—Docetaxel—ovarian cancer	0.000327	0.00322	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000325	0.0032	CcSEcCtD
Fluticasone furoate—Infection—Paclitaxel—ovarian cancer	0.000323	0.00318	CcSEcCtD
Fluticasone furoate—Dizziness—Vinorelbine—ovarian cancer	0.00032	0.00315	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Paclitaxel—ovarian cancer	0.000319	0.00314	CcSEcCtD
Fluticasone furoate—Bronchitis—Epirubicin—ovarian cancer	0.000315	0.0031	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000313	0.00308	CcSEcCtD
Fluticasone furoate—Rash—Vinorelbine—ovarian cancer	0.000305	0.003	CcSEcCtD
Fluticasone furoate—Dermatitis—Vinorelbine—ovarian cancer	0.000305	0.003	CcSEcCtD
Fluticasone furoate—Headache—Vinorelbine—ovarian cancer	0.000303	0.00298	CcSEcCtD
Fluticasone furoate—Palpitations—Docetaxel—ovarian cancer	0.000299	0.00294	CcSEcCtD
Fluticasone furoate—Cough—Docetaxel—ovarian cancer	0.000295	0.0029	CcSEcCtD
Fluticasone furoate—Bronchitis—Doxorubicin—ovarian cancer	0.000291	0.00287	CcSEcCtD
Fluticasone furoate—Dyspnoea—Paclitaxel—ovarian cancer	0.00029	0.00286	CcSEcCtD
Fluticasone furoate—Nausea—Vinorelbine—ovarian cancer	0.000287	0.00283	CcSEcCtD
Fluticasone furoate—NR3C1—myometrium—ovarian cancer	0.000287	0.0681	CbGeAlD
Fluticasone furoate—Conjunctivitis—Epirubicin—ovarian cancer	0.000284	0.00279	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Docetaxel—ovarian cancer	0.000276	0.00272	CcSEcCtD
Fluticasone furoate—NR3C1—embryo—ovarian cancer	0.000276	0.0655	CbGeAlD
Fluticasone furoate—Epistaxis—Epirubicin—ovarian cancer	0.000275	0.00271	CcSEcCtD
Fluticasone furoate—Infection—Docetaxel—ovarian cancer	0.000274	0.0027	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Docetaxel—ovarian cancer	0.000271	0.00266	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Doxorubicin—ovarian cancer	0.000262	0.00258	CcSEcCtD
Fluticasone furoate—Pharyngitis—Epirubicin—ovarian cancer	0.00026	0.00256	CcSEcCtD
Fluticasone furoate—Urticaria—Paclitaxel—ovarian cancer	0.000259	0.00255	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Epirubicin—ovarian cancer	0.000257	0.00253	CcSEcCtD
Fluticasone furoate—Body temperature increased—Paclitaxel—ovarian cancer	0.000257	0.00253	CcSEcCtD
Fluticasone furoate—Epistaxis—Doxorubicin—ovarian cancer	0.000255	0.00251	CcSEcCtD
Fluticasone furoate—Visual impairment—Epirubicin—ovarian cancer	0.000252	0.00248	CcSEcCtD
Fluticasone furoate—Dyspnoea—Docetaxel—ovarian cancer	0.000246	0.00242	CcSEcCtD
Fluticasone furoate—Eye disorder—Epirubicin—ovarian cancer	0.000245	0.00241	CcSEcCtD
Fluticasone furoate—Pharyngitis—Doxorubicin—ovarian cancer	0.000241	0.00237	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00024	0.00236	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000238	0.00234	CcSEcCtD
Fluticasone furoate—Immune system disorder—Epirubicin—ovarian cancer	0.000237	0.00233	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Epirubicin—ovarian cancer	0.000236	0.00232	CcSEcCtD
Fluticasone furoate—Visual impairment—Doxorubicin—ovarian cancer	0.000234	0.0023	CcSEcCtD
Fluticasone furoate—Eye disorder—Doxorubicin—ovarian cancer	0.000226	0.00223	CcSEcCtD
Fluticasone furoate—NR3C1—epithelium—ovarian cancer	0.000225	0.0535	CbGeAlD
Fluticasone furoate—NR3C1—uterine cervix—ovarian cancer	0.000223	0.053	CbGeAlD
Fluticasone furoate—Diarrhoea—Paclitaxel—ovarian cancer	0.000223	0.00219	CcSEcCtD
Fluticasone furoate—Back pain—Epirubicin—ovarian cancer	0.000221	0.00217	CcSEcCtD
Fluticasone furoate—Immune system disorder—Doxorubicin—ovarian cancer	0.000219	0.00215	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000218	0.00215	CcSEcCtD
Fluticasone furoate—Body temperature increased—Docetaxel—ovarian cancer	0.000218	0.00215	CcSEcCtD
Fluticasone furoate—Dizziness—Paclitaxel—ovarian cancer	0.000215	0.00212	CcSEcCtD
Fluticasone furoate—NR3C1—decidua—ovarian cancer	0.000213	0.0505	CbGeAlD
Fluticasone furoate—Agitation—Epirubicin—ovarian cancer	0.00021	0.00206	CcSEcCtD
Fluticasone furoate—Rash—Paclitaxel—ovarian cancer	0.000205	0.00202	CcSEcCtD
Fluticasone furoate—Dermatitis—Paclitaxel—ovarian cancer	0.000205	0.00202	CcSEcCtD
Fluticasone furoate—Back pain—Doxorubicin—ovarian cancer	0.000204	0.00201	CcSEcCtD
Fluticasone furoate—Headache—Paclitaxel—ovarian cancer	0.000204	0.00201	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Docetaxel—ovarian cancer	0.000203	0.002	CcSEcCtD
Fluticasone furoate—NR3C1—endometrium—ovarian cancer	0.000202	0.048	CbGeAlD
Fluticasone furoate—Palpitations—Epirubicin—ovarian cancer	0.000201	0.00198	CcSEcCtD
Fluticasone furoate—Cough—Epirubicin—ovarian cancer	0.000199	0.00196	CcSEcCtD
Fluticasone furoate—Agitation—Doxorubicin—ovarian cancer	0.000194	0.00191	CcSEcCtD
Fluticasone furoate—Nausea—Paclitaxel—ovarian cancer	0.000193	0.0019	CcSEcCtD
Fluticasone furoate—Diarrhoea—Docetaxel—ovarian cancer	0.000189	0.00186	CcSEcCtD
Fluticasone furoate—NR3C1—gonad—ovarian cancer	0.000187	0.0445	CbGeAlD
Fluticasone furoate—Palpitations—Doxorubicin—ovarian cancer	0.000186	0.00184	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000186	0.00183	CcSEcCtD
Fluticasone furoate—NR3C1—uterus—ovarian cancer	0.000186	0.0442	CbGeAlD
Fluticasone furoate—Infection—Epirubicin—ovarian cancer	0.000185	0.00182	CcSEcCtD
Fluticasone furoate—Cough—Doxorubicin—ovarian cancer	0.000184	0.00181	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Epirubicin—ovarian cancer	0.000182	0.0018	CcSEcCtD
Fluticasone furoate—Dizziness—Docetaxel—ovarian cancer	0.000182	0.0018	CcSEcCtD
Fluticasone furoate—Betamethasone—ABCB1—ovarian cancer	0.000182	0.0736	CrCbGaD
Fluticasone furoate—Rash—Docetaxel—ovarian cancer	0.000174	0.00171	CcSEcCtD
Fluticasone furoate—Dermatitis—Docetaxel—ovarian cancer	0.000174	0.00171	CcSEcCtD
Fluticasone furoate—Headache—Docetaxel—ovarian cancer	0.000173	0.0017	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000172	0.0017	CcSEcCtD
Fluticasone furoate—Infection—Doxorubicin—ovarian cancer	0.000171	0.00168	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Doxorubicin—ovarian cancer	0.000169	0.00166	CcSEcCtD
Fluticasone furoate—NR3C1—female reproductive system—ovarian cancer	0.000167	0.0397	CbGeAlD
Fluticasone furoate—Dyspnoea—Epirubicin—ovarian cancer	0.000166	0.00163	CcSEcCtD
Fluticasone furoate—Nausea—Docetaxel—ovarian cancer	0.000164	0.00161	CcSEcCtD
Fluticasone furoate—NR3C1—bone marrow—ovarian cancer	0.000158	0.0375	CbGeAlD
Fluticasone furoate—Dyspnoea—Doxorubicin—ovarian cancer	0.000153	0.00151	CcSEcCtD
Fluticasone furoate—ABCB1—myometrium—ovarian cancer	0.000153	0.0365	CbGeAlD
Fluticasone furoate—NR3C1—female gonad—ovarian cancer	0.000152	0.0361	CbGeAlD
Fluticasone furoate—NR3C1—vagina—ovarian cancer	0.000151	0.0359	CbGeAlD
Fluticasone furoate—Urticaria—Epirubicin—ovarian cancer	0.000148	0.00146	CcSEcCtD
Fluticasone furoate—ABCB1—embryo—ovarian cancer	0.000148	0.0351	CbGeAlD
Fluticasone furoate—Body temperature increased—Epirubicin—ovarian cancer	0.000147	0.00145	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Epirubicin—ovarian cancer	0.000137	0.00135	CcSEcCtD
Fluticasone furoate—Urticaria—Doxorubicin—ovarian cancer	0.000137	0.00135	CcSEcCtD
Fluticasone furoate—Body temperature increased—Doxorubicin—ovarian cancer	0.000136	0.00134	CcSEcCtD
Fluticasone furoate—NR3C1—testis—ovarian cancer	0.000135	0.0321	CbGeAlD
Fluticasone furoate—Diarrhoea—Epirubicin—ovarian cancer	0.000127	0.00125	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000127	0.00125	CcSEcCtD
Fluticasone furoate—CYP3A4—female reproductive system—ovarian cancer	0.000126	0.03	CbGeAlD
Fluticasone furoate—Dizziness—Epirubicin—ovarian cancer	0.000123	0.00121	CcSEcCtD
Fluticasone furoate—ABCB1—epithelium—ovarian cancer	0.00012	0.0286	CbGeAlD
Fluticasone furoate—ABCB1—uterine cervix—ovarian cancer	0.000119	0.0284	CbGeAlD
Fluticasone furoate—Diarrhoea—Doxorubicin—ovarian cancer	0.000118	0.00116	CcSEcCtD
Fluticasone furoate—Rash—Epirubicin—ovarian cancer	0.000117	0.00116	CcSEcCtD
Fluticasone furoate—Dermatitis—Epirubicin—ovarian cancer	0.000117	0.00115	CcSEcCtD
Fluticasone furoate—Headache—Epirubicin—ovarian cancer	0.000117	0.00115	CcSEcCtD
Fluticasone furoate—Dizziness—Doxorubicin—ovarian cancer	0.000114	0.00112	CcSEcCtD
Fluticasone furoate—ABCB1—decidua—ovarian cancer	0.000114	0.027	CbGeAlD
Fluticasone furoate—Nausea—Epirubicin—ovarian cancer	0.000111	0.00109	CcSEcCtD
Fluticasone furoate—Rash—Doxorubicin—ovarian cancer	0.000109	0.00107	CcSEcCtD
Fluticasone furoate—Dermatitis—Doxorubicin—ovarian cancer	0.000108	0.00107	CcSEcCtD
Fluticasone furoate—ABCB1—endometrium—ovarian cancer	0.000108	0.0257	CbGeAlD
Fluticasone furoate—Headache—Doxorubicin—ovarian cancer	0.000108	0.00106	CcSEcCtD
Fluticasone furoate—Dexamethasone—ABCB1—ovarian cancer	0.000106	0.0428	CrCbGaD
Fluticasone furoate—Nausea—Doxorubicin—ovarian cancer	0.000102	0.00101	CcSEcCtD
Fluticasone furoate—ABCB1—gonad—ovarian cancer	0.0001	0.0238	CbGeAlD
Fluticasone furoate—ABCB1—uterus—ovarian cancer	9.95e-05	0.0237	CbGeAlD
Fluticasone furoate—NR3C1—lymph node—ovarian cancer	9.78e-05	0.0232	CbGeAlD
Fluticasone furoate—ABCB1—female reproductive system—ovarian cancer	8.95e-05	0.0213	CbGeAlD
Fluticasone furoate—ABCB1—bone marrow—ovarian cancer	8.45e-05	0.0201	CbGeAlD
Fluticasone furoate—ABCB1—female gonad—ovarian cancer	8.14e-05	0.0194	CbGeAlD
Fluticasone furoate—ABCB1—vagina—ovarian cancer	8.09e-05	0.0192	CbGeAlD
Fluticasone furoate—ABCB1—testis—ovarian cancer	7.22e-05	0.0172	CbGeAlD
Fluticasone furoate—ABCB1—lymph node—ovarian cancer	5.23e-05	0.0124	CbGeAlD
